Risk of Covid infection, intensive care unit admissions and deaths remained high among recipients of the Sinopharm vaccine in the Kingdom.
This follows a study into the Kingdom’s Covid-19 related outcomes from a national database, taking into consideration the administering of four vaccines to tackle the pandemic risk.
The study was carried out by Dr Sid Mukherjee, a researcher in the field
